BudGenius.com Medical Marijuana Testing BudGenius

New Post Public Reply Private Reply Replies (0) Message Board
john1234
BudGenius.com


Medical Marijuana Testing


BudGenius works with dispensary, growers, product manufacturers, and patients. We accept selections from your strain inventory and return to you the most comprehensive reporting package in the industry.

All of your testing results are stored online, and should you choose, become accessible by the public. This helps to organize your testing history into one convenient location for everyone. We also integrate popular social media tools so that you can promote your great strains. In fact, every strain we test has a custom web page created just for you!

Pricing


All BudGenius services are simply priced: Only $50 per strain.


This is an all-inclusive price for everything! We believe in giving the best quality at the best pricing so that all patients receive consistent accurate results. Call us. We are happy to answer all of your questions .

What You Receive with Every Test

•Fast Results! Our labs are designed around custom software that speeds processing time.
•The BudGenius StrainId Card™. We are the only testing agency in the nation to provide high security strain identification cards. This ensures to patients that your test results are genuine, accurate, and not modified through Photoshop trickery.
•The BudGenius Certified Strain Report™. shows you intimate details on how your strain performed through a series of testing processes.
•The BudGenius ONLINE Strain Report™. is a custom webpage for your strain to be shared online, in social media, and also magazine advertisements.

•A set of BudGenius StrainCertified Labels™. With so many different strains available today, it is important for your customers to be able to have access their cannabis details at all times.
•The BudGenius Effects Analysis™. The BudGenius Engine combines scientific and social data to provide patients an effects analysis for every strain tested.
•BudGenius Management Tools™. The moment you become a BudGenius customer you have a full set of online tools available to you. As a dispensary this will help you reorder and track popular medications from trusted growers. As a grower this empowers you to more effectively track the quality and consistency of each product harvest.


But Wait, You Get More!

•BudGenius Strain Badges™ (online mini-graphics)
•Strain Posting to Twitter, Facebook, and more.
•Free Internet Advertising Tools
•Community Reviews
•Patient Rewards for Community Interaction


Ready to Get Started?


All of this for just one low cost per strain? Yes! --> Click here to begin

reference source
http://budgenius.com/services.html

Rightsmile Inc. (RIGH) Stock Research Links

RIGH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Resorts World NYC Unveils Luxe High-Roller Room

Updated Category News Views 6

New Frontier for New York's Gaming Scene The glitz and glamour of high-roller gaming just found a new home in the heart of Queens. Resorts World New York City (RWNYC), which has been turning heads for over a decade, has now cranked the luxe up a notch with the introduction of its International Room. This isn't just any room, folks; we're talking about a high-limit gaming...

Continue Reading
Voter Power Flexes with Early Voting Celebrations

Updated Category News Views 16

Voter Engagement Hits a New High with Nationwide Parties Well, look at that—voter turnout's got its own party scene now, and it's making waves. As Vote Early Day approaches, the folks at When We All Vote are cranking up the volume on civic engagement with what's touted as the biggest Party at the Polls program yet. With almost 700 get-togethers riffing across the U.S.,...

Continue Reading
Unicycive's Stock Plunge: Fraud Suit and FDA Hurdles

Updated Category News Views 8

Unicycive's Tumultuous Journey Lately, it's been a rocky road for Unicycive Therapeutics, Inc., with their stock free-falling 39.1% in the span of a heartbeat on June 30, 2026. What sparked this nosedive? The FDA kicked back their revised New Drug Application for a kidney disease treatment yet again, spotlighting old manufacturing issues never nipped in the bud. Talk...

Continue Reading
Rakuten Medical's Long-Term Data Shows Promise

Updated Category News Views 4

This Isn't Just Another Cancer Update Alright, folks, let's unwrap what's happening today with Rakuten Medical. They've thrown some serious numbers into the ring at the ESMO Congress 2026 in Madrid. We're talking long-term follow-up results of their ASP-1929 photoimmunotherapy combined with pembrolizumab in tackling recurrent and metastatic head and neck squamous cell...

Continue Reading
Ruth, Mickey, Superman: Morphy's Auction Smorgasbord

Updated Category News Views 3

A Surreal Gathering of Icons and Memorabilia Who'd have thought you could snag both Babe Ruth and Mickey Mouse in one fell swoop? Well, come November 10-12, 2026, fans and collectors alike will have the opportunity at Morphy Auctions in Denver, PA. It's a dizzying array of Americana where cultural legend meets sports royalty, and we're not talking pocket change here. Babe...

Continue Reading
Venture Dock Fosters Global Startup Ecosystems

Updated Category News Views 6

Venture Dock Connects the Global Startup Dots When it comes down to bridging the gap between promising innovation and commercial success, you'd be hard-pressed to find a better player than Venture Dock. In a world filled with buzzwords and fluff, these guys are socketed deep in the guts of genuine startup development — and they're making waves with their recent...

Continue Reading
D-Wave Investors Face Pressure Ahead of December 15

Updated Category News Views 3

Investors Eye December 15 Deadline Nothing like a looming deadline to stir up some anxiety among investors, and that's exactly what's going down at D-Wave Quantum Inc. right now. We're talking about the class action lawsuit spearheaded by the firm Robbins Geller Rudman & Dowd LLP. They've sent out a call to arms for investors who suffered significant losses from February...

Continue Reading
First Citizens Surprises with Q3 Gains and Buyback Plan

Updated Category News Views 3

Unexpected Third Quarter Tailwinds for First Citizens There are days in this trading gig when a bank I'll barely sneeze at hits out of the park. First Citizens BancShares (NASDAQ:FCNCA) pulled off such a feat, wringing out a third-quarter 2026 performance that beat their own benchmarks. They threw $600 million back to shareholders in repurchased stocks while repaying an...

Continue Reading
California Waste Solutions: Investing in Vietnam's Future

Updated Category News Views 3

Some folks see trash. David Duong sees hope—and dollar signs. This man ain't just talking trash collection; he's flipping waste into opportunity and, more importantly, into core community building in Vietnam. Over at Vietnam Waste Solutions, a subsidiary of California Waste Solutions, they're blending environmental breakthroughs with good old-fashioned community values....

Continue Reading
Kahn Swick & Foti Questions Valaris Transocean Deal

Updated Category News Views 6

Valaris and Transocean: A Closer Look at the Deal Diving right into it, folks, we've got Kahn Swick & Foti, LLC taking a hard look at the proposed sale of Valaris Limited over to Transocean Ltd. Now, on paper, this might seem like another run-of-the-mill corporate shuffle, but not so fast. There're a few rocky waters here that might make even the hardest boiled of us...

Continue Reading

Top 5 Most Recently Viewed Articles

Nasdaq Inc. Reveals Strategy for Cash Tender Offers on Debt

Updated Category News Views 117

Nasdaq Inc. Cash Tender Offers Overview Nasdaq, Inc. (NASDAQ: NDAQ) has made headlines with its recent announcements regarding cash tender offers for up to $218 million of its outstanding debt securities. This initiative involves a strategy to repurchase existing Notes, which consist of senior notes due in 2028, 2034, and 2052. The company has decided to enhance the...

Continue Reading
Ultima Markets Partners with Inter for Exciting New Venture

Updated Category News Views 166

Ultima Markets Partners with Inter in Asia Ultima Markets has officially joined forces with FC Internazionale Milano (Inter) as their Official Regional Partner in Asia. This partnership marks a significant step in Ultima Markets' growth strategy, symbolizing a unique collaboration that merges the world of finance with the excitement of football, creating a distinctive...

Continue Reading
Ribo Secures EMA Orphan Drug Status for RBD1016 Against HDV

Updated Category News Views 191

Ribo Life Science Gains Important EMA Approval BEIJING and GOTHENBURG, Sweden – In a significant advancement for the medical community, Suzhou Ribo Life Science Co., Ltd. along with Ribocure Pharmaceuticals AB has achieved a noteworthy milestone. The European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) for RBD1016, a promising therapeutic aimed at...

Continue Reading
Projected Growth of the Wood Pellets Market Driving Investment

Updated Category News Views 92

Overview of the Wood Pellets Market Growth The latest insights reveal that the wood pellets market is on a trajectory to significantly grow, with projections indicating it could reach an impressive valuation of USD 20.5 billion. This growth is primarily fueled by the rising global demand for renewable energy sources, a trend that is transforming the energy landscape. Key...

Continue Reading
Surge Copper Corp. Engages Investors in Virtual Conference

Updated Category News Views 131

Engagement Opportunity with Surge Copper Corp. Surge Copper Corp. (TSXV: SURG, OTCQB: SRGXF) is set to engage with investors at an upcoming virtual investor conference. This event, held through VirtualInvestorConferences.com, will be hosted by Leif Nilsson, the company's CEO, providing a platform for potential investors to learn more about Surge's ongoing projects focused...

Continue Reading